BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 12138370)

  • 1. Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease.
    Domagala TB; Adamek L; Nizankowska E; Sanak M; Szczeklik A
    Blood Coagul Fibrinolysis; 2002 Jul; 13(5):423-31. PubMed ID: 12138370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients.
    Morelli VM; Lourenço DM; D'Almeida V; Franco RF; Miranda F; Zago MA; Noguti MA; Cruz E; Kerbauy J
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):271-5. PubMed ID: 11943942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.
    Hanson NQ; Aras O; Yang F; Tsai MY
    Clin Chem; 2001 Apr; 47(4):661-6. PubMed ID: 11274015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism.
    De Stefano V; Casorelli I; Rossi E; Zappacosta B; Leone G
    Semin Thromb Hemost; 2000; 26(3):305-11. PubMed ID: 11011848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The common mutations C677T and A1298C in the human methylenetetrahydrofolate reductase gene are associated with hyperhomocysteinemia and cardiovascular disease in hemodialysis patients.
    Haviv YS; Shpichinetsky V; Goldschmidt N; Atta IA; Ben-Yehuda A; Friedman G
    Nephron; 2002 Sep; 92(1):120-6. PubMed ID: 12187094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis.
    Koch HG; Nabel P; Junker R; Auberger K; Schobess R; Homberger A; Linnebank M; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S113-6. PubMed ID: 10650848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of thrombotic risk factors in end-stage renal disease.
    Tripathi G; Sankhwar SN; Sharma RK; Baburaj VP; Agrawal S
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):132-40. PubMed ID: 19520684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients.
    Gemmati D; Serino ML; Trivellato C; Fiorini S; Scapoli GL
    Haematologica; 1999 Sep; 84(9):824-8. PubMed ID: 10477457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis.
    Keijzer MB; den Heijer M; Blom HJ; Bos GM; Willems HP; Gerrits WB; Rosendaal FR
    Thromb Haemost; 2002 Nov; 88(5):723-8. PubMed ID: 12428084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of prothrombotic risk factors in patients with deep venous thrombosis and controls: their implications for thrombophilia screening in Chilean subjects.
    Guzmán N; Salazar LA
    Genet Test Mol Biomarkers; 2010 Oct; 14(5):599-602. PubMed ID: 20707729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary thrombophilia in Mexico. II. Factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase C677T polymorphism in thrombophilic Mexican mestizos.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ramírez-Cisneros FJ
    Am J Hematol; 2001 Jan; 66(1):28-31. PubMed ID: 11426488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
    Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome.
    Li XM; Wei YF; Hao HL; Hao YB; He LS; Li JD; Mei B; Wang SY; Wang C; Wang JX; Zhu JZ; Liang JQ
    Am J Hematol; 2002 Sep; 71(1):11-4. PubMed ID: 12221667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic cases.
    Hainaut P; Jaumotte C; Verhelst D; Wallemacq P; Gala JL; Lavenne E; Heusterspreute M; Zech F; Moriau M
    Thromb Res; 2002 Apr; 106(2):121-5. PubMed ID: 12182910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations.
    Friedman G; Goldschmidt N; Friedlander Y; Ben-Yehuda A; Selhub J; Babaey S; Mendel M; Kidron M; Bar-On H
    J Nutr; 1999 Sep; 129(9):1656-61. PubMed ID: 10460200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methionine synthase A2756G and methylenetetrahydrofolate reductase A1298C polymorphisms are not risk factors for idiopathic venous thromboembolism.
    Salomon O; Rosenberg N; Zivelin A; Steinberg DM; Kornbrot N; Dardik R; Inbal A; Seligsohn U
    Hematol J; 2001; 2(1):38-41. PubMed ID: 11920232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association study of methylenetetrahydrofolate reductase C677T mutation with cerebral venous thrombosis in an Iranian population.
    Ghaznavi H; Soheili Z; Samiei S; Soltanpour MS
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):869-73. PubMed ID: 26083986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylenetetrahydrofolate reductase (C677T and A1298C) polymorphisms, hyperhomocysteinemia, and ischemic stroke in Tunisian patients.
    Fekih-Mrissa N; Mrad M; Klai S; Mansour M; Nsiri B; Gritli N; Mrissa R
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):465-9. PubMed ID: 23642756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations.
    Isotalo PA; Wells GA; Donnelly JG
    Am J Hum Genet; 2000 Oct; 67(4):986-90. PubMed ID: 10958762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.